Goodwin
Sarah Bock
- Deals
- 4
- Latest
- Jun 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 4 deals
Often works with
- Artimus Cunningham 3 deals together
- Daniel Karelitz 3 deals together
- Arman Oruc 3 deals together
- Wei Xu 2 deals together
- Evan Lee 2 deals together
- Christina Lewis 2 deals together
- Susan Lee 2 deals together
- Justin Pierce 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jun 2026 | Alloy Enterprises | – | Johnson Controls | Acquisition | Legal adviser to Alloy Enterprises (target) | Announced | – | Manufacturing+2 | Johnson Controls acquisition of Alloy Enterprises |
| Apr 2026 | Kelonia Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Kelonia Therapeutics (target) | Announced | 7,000.0 | Biotech+2 | Eli Lilly and Company acquisition of Kelonia Therapeutics |
| Apr 2026 | Tubulis | EQT Life Sciences (LSP 7 fund) | Gilead Sciences | Acquisition | Legal adviser to Tubulis (target) | Announced | 3,150.0 | Biotech+2 | Gilead Sciences acquisition of Tubulis |
| Feb 2026 | Orna Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Orna Therapeutics (target) | Announced | 2,400.0 | Biotech+1 | Eli Lilly and Company acquisition of Orna Therapeutics |
Deals where Sarah Bock is named on the firm's deal team, by the firm or the press.